ALSPW Share Price Performance
Recent ALSPW News & Updates
No updates
Spineway SA Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.19
- Gross Margin
- 41.96%
- Net Profit Margin
- -30.35%
- Debt/Equity Ratio
- 7.4%
Spineway SA Competitors
About ALSPW
- Founded
- 2005
- Employees
- 49
- CEO
- WebsiteView website
Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The company was incorporated in 2005 and is headquartered in Ecully, France.
French Market Performance
- 7 Days: -3.9%
- 3 Months: -3.5%
- 1 Year: 2.8%
- Year to Date: 0.7%
Over the last 7 days, the market has dropped 3.9%, driven by a decline of 7.9% in the Consumer Discretionary sector. Overall the market has been flat in the last year. Looking forward, earnings are forecast to grow by 12% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading